Adaptive treatment margins to reduce organs at risk dose in patients with no or minimal anatomical changes in radiotherapy of non-small cell lung cancer

在非小细胞肺癌放射治疗中,对于无或仅有轻微解剖结构改变的患者,可采用自适应治疗边界来降低危及器官的辐射剂量。

阅读:2

Abstract

BACKGROUND AND PURPOSE: In non-small cell lung cancer (NSCLC) a significant portion of the planning target volume (PTV) margin accommodates for anatomical changes during treatment. Patients with no or minimal anatomical changes might therefore benefit from a reduced PTV margin, resulting in lower organ at risk (OAR) doses. We evaluated a plan of the day approach using different PTV margins to quantify its effect on OAR and clinical target volume (CTV) dose. MATERIALS AND METHODS: Twenty NSCLC patients were included in this retrospective study. CBCTs of all fractions were evaluated using an image-guided radiotherapy (IGRT) protocol to classify fractions into two groups: no or minimal anatomical changes to which reduced PTV margin plans (5 or 2 mm) were assigned, or with anatomical changes that received the reference treatment plan (8 mm PTV margin). OAR doses were investigated and CTV coverage was evaluated using CBCT dose recalculations. RESULTS: All plans showed decreased OAR dose when the PTV margin was reduced from 8 mm to 5 mm or 2 mm. The IGRT protocol selected 254/600 fractions in 19/20 patients, that could be treated with a smaller margin. CTV V(95%) remained ≥95% in 94% of the 5 mm plans and 87% of the 2 mm plans, compared to 98% of the reference 8 mm plans. CONCLUSION: The IGRT protocol could identify fractions with no or minimal anatomical changes allowing a plan of the day approach to reduce PTV margins. Target coverage remained adequate in the majority of patients, while reducing OAR doses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。